News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,091 Results
Type
Article (101)
Press Release (990)
Section
Business (311)
Deals (37)
Drug Development (235)
FDA (6)
Job Trends (6)
News (569)
Policy (37)
Tag
Academia (8)
Alliances (113)
Alzheimer's disease (4)
Approvals (6)
Artificial intelligence (2)
Best Places to Work (6)
Brain cancer (1)
Breast cancer (1)
Cancer (8)
Cell therapy (1)
Clinical research (169)
Collaboration (1)
COVID-19 (2)
CRISPR (1)
Data (8)
Diabetes (1)
Diagnostics (11)
Drug discovery (1)
Earnings (53)
Events (132)
FDA (9)
Funding (2)
Gene editing (1)
Gene therapy (2)
GLP-1 (2)
Government (5)
Healthcare (16)
Infectious disease (2)
IPO (20)
Legal (1)
Liver cancer (1)
Lung cancer (1)
Lymphoma (1)
Medical device (16)
Medtech (16)
Mergers & acquisitions (18)
Metabolic disorders (2)
Neuroscience (6)
NextGen Class of 2024 (6)
Non-profit (5)
Northern California (5)
Obesity (1)
Parkinson's disease (2)
People (124)
Phase I (83)
Phase II (86)
Phase III (35)
Pipeline (2)
Postmarket research (2)
Preclinical (43)
Rare diseases (1)
Real estate (6)
Regulatory (34)
Research institute (7)
Southern California (1)
Startups (13)
United States (15)
Date
Last 30 days (5)
Last 365 days (64)
2024 (64)
2023 (73)
2022 (98)
2021 (100)
2020 (72)
2019 (67)
2018 (37)
2017 (74)
2016 (65)
2015 (101)
2014 (60)
2013 (49)
2012 (43)
2011 (59)
2010 (37)
Location
Asia (17)
Australia (6)
California (5)
Canada (2)
Europe (755)
Florida (1)
Massachusetts (2)
New Jersey (2)
New York (2)
North Carolina (1)
Northern California (5)
South America (1)
Southern California (1)
Texas (1)
Washington D.C. (1)
1,091 Results for "inserm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases
Evotec SE announced that the Company entered a partnership with Inserm, the French National Institute of Health and Medical Research, Lille University Hospital and Inserm Transfert to identify novel therapeutic targets and diagnostic and prognostic markers in obesity and metabolic diseases.
May 30, 2024
·
11 min read
Pharm Country
Tonix Pharmaceuticals Announces Research Agreement with the French National Institute of Health and Medical Research (Inserm) to Study the Mechanism of Oxytocin-Mediated Improvement of Eating Behaviors in Prader-Willi Mice
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), today announced that it has entered into a sponsored research agreement with Inserm Transfert, the private subsidiary of Inserm, on behalf of Inserm (the French National Institute of Health and Medical Research) and Aix-Marseille Université to study oxytocin in the genetically engineered mouse model of Prader-Willi syndrome.
February 28, 2022
·
9 min read
Business
LinKinVax and Inserm Transfert Enter Into an Exclusive Worldwide Licensing Agreement Covering Use of an Innovative Vaccine Platform
LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an innovative mechanism of action.
February 3, 2022
·
4 min read
Business
Tonix Pharmaceuticals Licenses Technology for Treating Prader-Willi Syndrome, a Rare Genetic Eating Disorder, from the French National Institute of Health and Medical Research (Inserm)
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced an agreement whereby Tonix has licensed technology using oxytocin-based therapeutics for the treatment of Prader-Willi syndrome and non-organic failure to thrive disease from Inserm.
February 11, 2021
·
11 min read
Drug Development
LinKinVax Welcomes Interim Results of the ANRS VRI06 Phase I Trial Evaluating a Novel HIV Vaccine Candidate
LinKinVax, a clinical-stage biotechnology company, welcomes the interim results of the ANRS VRI06 Phase I trial evaluating a preventive HIV vaccine and conducted by the sponsor INSERM-ANRS and the Vaccine Research Institute.
February 22, 2023
·
5 min read
Pharm Country
Cytovia Therapeutics partners with Inserm to develop selective CD38 NK therapeutics and offer new treatment options for Multiple Myeloma patients
Cytovia Therapeutics, an emerging biopharmaceutical company, announces that it has entered a research and licensing agreement with Inserm to develop NK engager bi-specific antibodies and iPSC CAR NK cell therapy targeting CD38, a key marker of multiple myeloma.
October 8, 2020
·
4 min read
Drug Development
Poietis is starting a three-year collaboration concerning the use of Poietis’ bioprinting technology to develop a functionalized clinical grade cardiac patch
Collaboration with Professor Philippe Menasché (PARCC Cardiovascular Research Center - Inserm - Université Paris Cité - UMR 970 and Cardiovascular Surgery Department, Georges Pompidou European Hospital)
October 3, 2022
·
2 min read
Inserm moves to electronic lab with adoption of Labguru
BioData has announced the roll-out of its Electronic Lab Notebook (ELN) platform, Labguru, with Inserm, France’s only public research institute to focus entirely on human health.
June 8, 2019
·
3 min read
BioCapital
The French National Institute of Health and Medical Research (Inserm) Selects Expert System’s Artificial Intelligence to Support COVID-19 Research
The global Artificial Intelligence company Expert System announced today that the French National Institute of Health and Medical Research, Inserm, has decided to implement its Clinical Research Navigator (CRN) tool and make it available to 100 of its researchers for an evaluation period of six months.
June 4, 2020
·
2 min read
Press Releases
Results from a Phase I clinical trial of a dendritic cell targeting prophylactic HIV vaccine published in the Journal eClinical Medicine
October 2, 2024
·
7 min read
1 of 110
Next